Recent Finacing
Recent Raise
AnchorDx develops DNA methylation NGS diagnostics for cancer screening and early detection, including PulmoSeek for pulmonary nodule management, PulmoSeek Plus (liquid biopsy + LDCT), and a multicenter lung-screening trial.
Focus Areas
Recent Investors
Total Raised
Funding round
Investors
